The ATM gene in the pathogenesis of mantle-cell lymphoma

Ann Oncol. 2000:11 Suppl 1:127-30.

Abstract

Background: Mantle-cell lymphoma (MCL) is genetically characterized by the translocation t(11;14)(q13;q32) leading to an overexpression of cyclin-D1, but additional chromosomal abnormalities appear to be required for MCL pathogenesis.

Patients and methods: Deletions involving chromosome 11q, which were recently found as recurrent aberrations in MCL, were analyzed at the molecular level in a series of 81 MCL by fluorescence in situ hybridization (FISH) with probes from a contiguous set of yeast artificial chromosomes (YACs) spanning bands 11q14-q24.

Results and conclusions: Loss of chromosome 11 material was observed in 37 of the 81 MCL cases (46%). The consensus deletion comprised YAC 801e11 containing the ATM gene. The minimal region of loss was further narrowed with P1-derived artificial chromosome (PAC) probes. This allowed the identification of a deletion confined to the genomic region of ATM, which, together with intragenic mutations found in the coding sequence, suggests a role of ATM as a tumor suppressor gene in MCL.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ataxia Telangiectasia Mutated Proteins
  • Cell Cycle Proteins
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 11*
  • DNA-Binding Proteins
  • Female
  • Genes, bcl-1*
  • Humans
  • In Situ Hybridization, Fluorescence
  • Lymphoma, Mantle-Cell / genetics*
  • Lymphoma, Mantle-Cell / physiopathology
  • Male
  • Protein Serine-Threonine Kinases / genetics*
  • Sensitivity and Specificity
  • Translocation, Genetic
  • Tumor Suppressor Proteins

Substances

  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Tumor Suppressor Proteins
  • ATM protein, human
  • Ataxia Telangiectasia Mutated Proteins
  • Protein Serine-Threonine Kinases